Overall Technical outlook

Price Summary

On 2026-05-01, Regeneron Pharmaceuticals, Inc.'s stock began at 703.02, peaked at 714.48, declined to 700.26, and ended the day -0.23% down at 701.42, with 728877 shares traded.
The stock reached its highest price of 812.27 and lowest price of 483.07 over the last 52 weeks.
Analysts expect the price of REGN to vary between 730.0 and 1057.0, with an average expected price near 875.4489.

Technicals

Support and Resistance: The price of 701.42 is supported at 692.58 and capped by resistance at 733.78. These levels mark key points for Regeneron Pharmaceuticals, Inc. where the price could find stability, with 692.58 as a floor and 733.78 as a ceiling.
REGN supportResistance 9b222f
Support/Resistance for REGN


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
REGN aroon 9b222f
Aroon chart for Regeneron Pharmaceuticals, Inc.


Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
REGN bbands 9b222f
Bolinger Bands chart for Regeneron Pharmaceuticals, Inc.


Parabolic SAR: The PSAR for REGN remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
REGN psar 9b222f
Parabolic Stop and Reverse chart for Regeneron Pharmaceuticals, Inc.


Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for REGN, with no strong trend emerging.
REGN stoch 9b222f
Stochastic chart for Regeneron Pharmaceuticals, Inc.


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the slopes of the faster averages raise the possibility of a reversal for REGN. The weakening momentum in these shorter-term averages hints that the upward trend might be losing strength, suggesting that caution may be warranted.
REGN trippleSMA 9b222f
Tripple SMA chart for Regeneron Pharmaceuticals, Inc.


Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.